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Summary 
Natural immunity of humans to the cattle pathogen Trypanosoma  brucei brucei has been attrib- 
uted to the presence in normal human serum (NHS) of lyric factors for the parasites.  We anti 
others  have  shown  that  NHS  contains  two  trypanolytic factors  (herein  termed  TLF1  and 
TLF2) that can be separated by gel filtration. TLF1 copurifies with a subclass of high density li- 
poprotein (HDL), whereas TLF2 has a much higher molecular weight and does not appear to 
be a lipoprotein. We find that the trypanolytic activity of purified TLF1 is totally inhibited by 
exogenous haptoglobin (Hp) at concentrations (0.1  mg/ml) lower than those present in NHS 
(0.2-2 mg/ml). In contrast, exogenous Hp (up to 2.5 mg/ml) has no effect on the lyric activity 
of either NHS or isolated TLF2. Hp-depleted sera from patients with intravascular hemolysis is 
severalfold more trypanolytic than NHS. These sera contain only TLF1, and their lyric activity 
is totally abolished upon the addition of lip (0.1 mg/ml). When NHS containing different Hp 
allotypes is fractionated by gel filtration, TLF1 activity is either revealed or remains masked, de- 
pending on whether it coelutes with Hp. Masked TLF1 activity in the column fractions is re- 
vealed if Hp is removed by density gradient ultracentrifugation. We conclude that endogenous 
Hp inhibits TLF1 activity, and that TLF2 is the main trypanolytic factor in NHS. 
T 
WO  subspecies  of trypanosomes  can  cause  sleeping 
sickness:  Trypanosoma  brucei gambiense  (T.  b. gambiense) 
which causes  a chronic wasting disease  prevalent in West 
Africa, and Trypanosoma  brucei rhodesiense  ( T.  b.  rhodesiense) 
which is associated with an acute disease in East Africa. Al- 
though genetically distinct from each other, T.  b. gambiense 
and  T.  b.  rhodesiense  may be human-adapted forms of the 
cattle pathogen Trypanosoma brucei brucei (1, 2). Normal hu- 
man serum (NHS) 1 contains cytotoxic factor(s) that lyse the 
cattle but not the human pathogens. 
In  1978, Ikiflein  (3) identified the trypanolytic factor in 
NHS  as  high  density lipoprotein  (HDL, ~500  kD,  e  = 
1.063-1.216  g/ml).  Further studies have shown that lyric 
activity is associated with a minor subclass of HDL termed 
TLF  (trypanosome lyric factor)  (4-6).  Trypanosome lysis 
requires the endocytosis of TLF, followed by the disruption 
of acidic intracellular vesicles (lysosomes)  (7, 8). Recent ev- 
idence indicates that  the parasites  are  killed by the  acid- 
induced peroxidase activity of a complex formed from two 
components ofTLF, haptoglobin-related protein (Hpr) and 
1Abbreviations used in this paper: Hb, hemoglobin; HDL, high density lipo- 
protein; Hp, haptoglobin; Hpr, haptoglobin-related  protein; NHS, nor- 
real human serum; PNH, paroxysmal nocturnal hemoglobinuria; TBS, 
Tris-buffered  saline; TLF, trypanosome  lytic  factor. 
hemoglobin (Hb) (9). The Hpr is >90% identical to hapto- 
globin  (Hp)  (10), a plasma  glycoprotein that  avidly binds 
free Hb. Whereas there is a single type of Hpr, there are 
three main Hp types in humans, namely Hp 1-1, Hp 2-1, 
and Hp 2-2 (11). 
Human serum also contains a second poorly defined try- 
panolyric factor with properties distinct from HDL (1,000 
kD,  e  >1.25  g/rnl).  In  the  present  paper we  name  the 
HDL-like lyric factor TLF1, and the high molecular weight 
lyric factor TLF2. Previous reports document the presence 
of either or both lyric factors (12-15) in different individu- 
als; however, the molecular basis  for this heterogeneity is 
unknown. In this paper, we provide an explanation for this 
variability,  and  demonstrate  that  TLF2  is  the  main  try- 
panolytic factor in NHS. 
Materials and Methods 
Parasites and Sera.  Bloodstream forms of T. b. brucei (Trypano- 
some resource, Edinburgh  University, Edinburgh,  Scotland) 667 
stock (16) and T. b. rhodesiense  ETat 1.9R. Edinburgh  Trypanozoon 
antigen type 1.9 resistant (17) were used in all experiments. The 
former are sensitive to lysis by human serum; the latter are resis- 
tant and were used as the control for serum-specific trypanolysis. 
The parasites were grown in Swiss Webster mice, harvested mid 
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(18).  NHS and normal human plasma were obtained from blood 
collected from healthy volunteers, stored at 4~  and analyzed 
within 5 d. No differences in trypanolytic activity were found be- 
tween  plasma  and  serum.  Dr.  W.  ILosse  (Duke  University, 
Durham, NC) kindly provided sera from 19 patients with sickle- 
cell anemia and from 2 patients with paroxysmal nocturnal hemo- 
globinuria  (PNH).  Four  sera  from  PNH  patients  were  kindly 
provided by Dr~ L.  Luzzato (Memorial Sloan-Kettering Cancer 
Institute, New York, NY), and one serum from a PNH patient 
was  collected at  New  York  University Medical Center  (New 
York, NY; patient SB [19]). 
Parasite Lysis and Hp Inhibition Assays.  Parasite  lysis  was  deter- 
mined using a fluorescence-based assay as described (13).  Dilu- 
tions of lip prepared in 20 mM Tris, pH 7.5, and 130 mM NaC1 
(Tris-buffered saline [TBS])  were added to 9 vol of serum or se- 
rum fractions and incubated for 15 rain at 37~  Typically, 5 ~1 
of Hp dilution was added to 45 p~l of test sample. An equal vol- 
ume  (50  Izl)  of trypanosomes at  2  ￿  107/ml  in  high  glucose 
DME  (GIBCO BILL, Gaithersburg, MD) and 1.0% BSA (Sigma 
Chemical Co., St. Louis, MO) was then added; parasite survival 
was  determined after a  150-rain  incubation at  37~  Purified, 
lyophilized Hp  (Sigma Chemical Co.)  was  reconstituted to  25 
mg/nil in TBS and stored for up to 2 wk at 4~ 
Hp Assay and Typing,  Hp concentration in serum and serum 
fractions was determined by an ELISA. A standard procedure was 
followed  (20)  using an  IgG  fraction of rabbit anti-Hp  (Sigma 
Chemical  Co.)  as  capture  antibody (1:100  dilution),  and  goat 
anti-Hp (Sigma Chemical Co.) as the second antibody (1:1,000 
dilution). Botmd Hp--antibody complex was determined using rab- 
bit anti-goat IgG conjugated to alkaline phosphatase, and p-nitro- 
phenyl phosphate disodium (Pierce, tLockford, IL) as chromoge- 
nic substrate. Hp phenotyping of serum was determined by the 
separation of 2 ~1 of reduced serum proteins on 12% SDS-PAGE 
followed by their transfer onto polyvinyldifluoride  (PVDF) mem- 
brane (25 rain, 15 V). The membrane was blocked by incubation 
with 10% BSA in TBS, 0.1% Tween 20 for 1 h at room temper- 
ature (milk cannot be used as it contains Hp). The first antibody 
was an IgG fraction of rabbit anti-human Hp (1:10,000; Sigma 
Chemical  Co.),  and  the  second antibody was  goat  anti-rabbit 
conjugated to horseradish peroxidase (1:20,000;  Promega Corp., 
Madison, WI). The immunoreactive proteins were visualized by 
enhanced chemiluminescence (ECL; Dupont NEN, Boston, MA). 
Lipoprotein Isolation,  Lipoproteins were isolated from human 
serum by density gradient centrifugation according to the method 
of Poumay and tLonveaux-Dupal (21).  Fresh serum (12  nal) or 
pooled gel filtration fractions from  NHS  (12  ml)  were  mixed 
with solid KBr to give a final density of 1.25 g/ml. The lipopro- 
teins were then floated by centrifugation in a NVTi 60.1  rotor 
(Beckmann Instruments, Inc., Palo Alto, CA) (48 K, 16 h, 10~ 
ILoutinely, the top 2.5 mi, a bright orange layer containing lipo- 
proteins, was collected and dialysed against TBS for 4 h at 4~  in 
Slide-A-Lyzers (Pierce).  Lipoproteins (1  ml)  were  further  frac- 
tionated by gel filtration (see below). 
Gel Filtration of Lipoproteins and Serum.  Fresh  serum  was  frac- 
tionated by fast performance liquid chromatography (FPLC) us- 
hag Superose 6 HR. 10/30 column (Pharmacia Biotech Inc., Pis- 
cataway,  NJ).  Lipoproteins were  fractionated using Superose 6 
HtL  16/50  and Superose  12  HIL  16/50  columns connected in 
tandem. Sample volumes of 500 ~1 and 1 ml were applied to 10/ 
30  and  16/50  columns,  respectively. All columns  were equili- 
brated and run in TBS at 0.2 m]/min (10/30 column) or 0.4 ml/ 
rain (16/50 columns). 
Purification of lib.  Hb was purified based on  the  method  of 
Williams and Tsay (22),  but with modifications to minimize the 
formation of methemoglobin. Blood was drawn into citrate glu- 
cose  anticoagulant and  erythrocytes were  washed  six  times  in 
0.9% saline. All subsequent steps were done at 4~  Erythrocytes 
were lysed in 2 vol of 0.05 M  Tris-HC1, pH 7.6.  The lysate was 
centrifuged at 30,000 g for 15 rain, and the center two thirds of 
the solution was mixed with an equal volume of 0.05  M  Tris- 
HC1, pH 7.6. This solution was then added to an equal volume of 
50% DEAE-celhilose preequilibrated with 0.05 M  Tris-HCl, pH 
7.6, and mixed for 15 min. After centrifugation (3,000 g, 10 min), 
the supernatant was applied to a DEAE-cellulose column equili- 
brated with 0.05 M Tris-HC1, pH 8. Hb was eluted with a buffer 
containing 0.2 M  NaC1 and 0.05 M  Tris-HC1, pH 7.6. Early red 
fractions were discarded and collected fractions were adjusted to 
pH 8, aliquoted, and stored at -70~  Hb concentration was es- 
timated from absorbance at 541 nm [e(1%) =  8.63]  (22). 
Fractionation of Hp--Hb Complexes,  Hp  1-1  (Sigma  Chemical 
Co., St. Louis, MO) at 10 nag/m] was mixed with 1 vol of lib at 
25 mg/ml (twofold molar excess).  The mixture was incubated at 
37~  for  30  min,  and  100  ~1  was  applied to  a  Superose  12 
HR10/30 FPLC column. The sample was eluted with TBS at 0.2 
m]/min.  Purified Hp  1-1  and Hb were individually chromato- 
graphed under the same conditions. Hp  1-1  was used since the 
other Hp aUotypes form multimers and rifled to yield single peaks 
after fractionation. Hp 1-1 forms dimers of N90 kD which com- 
bine with Hb  dhners  to yield tetramers of '~150  kD.  Hp-Hb 
complexes are thus easBy separated from free Hp and Hb. 
Lysosomotrophic Agents.  Trypanosomes were preincubated with 
NH4CI (2.5-15 mM) or chloroquine (10-50 p~M) for 30 rain at 
37~  followed by incubation with either purified TFL1  (2 U), 
TLF2 (1 U) or TBS.  1 U  is equivalent to the amount of sample 
that lysed 50% of the trypanosomes in 150 rain, as previously de- 
fined (5). 
Results 
Inhibition of Isolated  TFL1 by Serum Hp.  A recent report 
suggests that the trypanolytic activity of NHS  is mediated 
by  the  peroxidase  activity  of  TLFl-associated  Hpr-Hb 
complexes (9). Hp, found in NHS at concentrations of 0.2-2 
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Figure 1.  Inhibition of TLF1 by Hp. Increasing concentrations of lip 
(mixed type) were added to dilutions of purified TLF1. Trypanosomes 
T. b. brucei  were then added (107/ml final concentration) and lysis  was de- 
termined after 150 rain at 37~ 
1024  Trypanosome Lyric Factors in Human Serum Table  1.  Relationship of lip Concentration and Type to Lytic 
Activity in Human Sera 
Hp concentration 
Serum  Hp allotype  Ixg rnl  -I  LU m1-1 
NHS 1  1-1  270  47 
NHS 2  2-1  320  38 
NHS 3  2-1  1,400  10 
NHS 4  2-1  512  12 
NHS 5  2-2  290  44 
NHS 6  2-2  1,800  32 
PNH 1  NA  <0.01  550 
PNH 2  NA  <0.01  400 
PNH 3  NA  10  400 
PNH 4  NA  26  360 
SCA 1  NA  <0.01  220 
SCA 2  NA  <0.01  350 
SCA 3  NA  <0.01  380 
SCA 4  NA  15  400 
SCA 5  NA  20  450 
SCA, sickle cell anemia. 
mg/ml, is >90% homologous to Hpr (10).  This raised the 
possibility that Hp might inhibit TLFl-mediated trypano- 
lysis, perhaps through the displacement of lib. Fig. 1 shows 
that  the  activity of TLF1,  isolated from  NHS  by density 
gradient  ultracentrifugarion  followed  by  gel  filtration,  is 
totally  suppressed  by  the  addition  of exogenous  Hp  at 
0.2 mg/ml. 
Comparison  of Trypanolytic  Activities  of NHS and Sera De- 
pleted of lip.  To  further  substantiate  the  finding that  se- 
rum  Hp  is a  potent inhibitor of TLF1,  we  measured  the 
trypanolytic activity of sera from patients with intravascular 
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Figure 2.  Lyric  activity of NHS and Hp-deficient  pathological sera. 
Parasite lysis was determined after addition of trypanosomes T. b. brucei 
(107/ml) to dilutions of NHS or of sera from patients with PNH (patients 
1 and 2, Table 1) and sickle-cell anemia (patient 1, Table 1). 
hemolysis (sickle-cell anemia and PNH).  In these patients, 
the free Hb released in the plasma binds with very high af- 
finity to Hp (dissociation constant >10 -is M; 23), and the 
complex is rapidly removed from the circulation. As shown 
in Table  1  and  Fig.  2,  Hp-depleted sera were  10-40-fold 
more lyric than NHS. Notably, there was no apparent cor- 
relation between the lyric activity of NHS  and either Hp 
concentration,  or Hp allotype. A  total of 12 NHS  and 20 
pathological  sera  (4  PNH,  16  sickle-cell  anemia)  were 
tested and only representative serum is shown. 
Inhibition of Serum Lytic Aaim'ty by Hp.  We  tested  whether, 
in addition to  its ability to  inhibit purified TLF1,  exoge- 
nous  Hp could also inhibit the lyric activity of whole hu- 
man sera. The addition of Hp to NHS,  even at high con- 
centrations  (2.5  mg/ml)  had no  effect on  its lyric activity 
(Fig.  3  a).  In  sharp  contrast however,  when  purified  Hp 
was  added  to  the  highly  trypanolytic serum  of a  patient 
with PNH,  there was a  dose-dependent abrogation of ac- 
rivity; complete inhibition was  obtained with  0.1  mg/ml 
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Figure 3.  Effect  of exogenous Hp and Hb on the trypanolytic activity 
of NHS and Hp-deficient sera. (a) Two dilutions of NHS, causing either 
100 or 75% lysis (triangles),  were incubated with increasing concentrations 
of lip (mixed types). Trypanosomes T. b. brucei (10V/ml) were then added 
and trypanolysis  determined. As shown, Hp had no effect on the lyric ac- 
tivity of NHS.  Increasing concentrations of Hp were also added to sera 
from patients with PNH or sickle-cell anemia (circles).  The trypanolytic 
activity of the patients' sera was inhibited by added Hp. Sera indicated in 
this figure are those in Table 1. (b) 5% PNH serum 1 (Table 1), which 
produced 100% tyrpanolysis,  was mixed with the indicated concentrations 
of either purified Hp 1-1 alone, Hp--Hb complexes, or Hb alone, and the 
trypanolytic activity of the serum subsequently measured. 
1025  Raper et al. Hp (Fig. 3 a). Both mixed and 1-1 Hp allotypes were effec- 
tive inhibitors of lysis (not shown). 
Inhibitory Activity of Hp--Hb  Complexes.  Inhibition  of 
TLF1 by Hp could be due to the displacement of lib from 
the  putative  Hpr-Hb  complex  in  TLF1.  To  test  this  hy- 
pothesis,  we  compared  the  inhibitory  activity  of isolated 
Hp  and  purified  Hp--Hb  complexes  of 1:1  stoichiometry. 
As  shown  in  Fig.  3  b,  Hp  and  Hp-Hb  complexes  were 
equally  inhibitory  over  a  wide  range  of concentrations. 
The addition of Hb alone had no effect on the lytic activity 
of either NHS  (not shown)  or PNH  serum (Fig.  3  b),  and 
purified Hp-Hb  complexes were nonlytic (not shown). 
Trypanolytic  Profiles of Sera Fractionated by  Gel  Filtration. 
To reveal the  origin  of the  non  Hp-inhibitable  activity of 
NHS (Fig. 3 a), we fractionated the sera of normal individ- 
uals  with  different  Hp  phenotypes  by gel filtration.  NHS 
containing Hp 1-1  gave two lyric peaks upon size fraction- 
ation,  one of high  molecular weight  (~1,000  kD;  TLF2), 
and  one  of between  150  and  600  kD  (TLF1)  (Fig.  4  a). 
Fractionation  of NHS  containing  Hp  2-1  or  2-2  yielded 
only one lytic peak corresponding to TLF2 (Fig. 4, b and c). 
Fractionation  of serum from a patient with sickle-cell ane- 
mia (Fig. 4 d), as well as ofsera from other patients with in- 
travascular  hemolysis  (not  shown),  also  yielded  only  one 
major  lyric  peak,  corresponding  to  TLF1  (Fig.  4  d).  We 
then  added  purified  Hp  (250  Ixg/ml)  to  each  serum frac- 
tion, and repeated the trypanolytic assay. The added Hp ef- 
fectively  inhibited  TLF1  activity,  but  had  no  effect  on 
TLF2 (Fig. 4, e-h). These findings account for the observa- 
tion that exogenous Hp inhibits the activity of Hp-depleted 
pathological sera, which contains litde or no TLF2 activity, 
but has no effect on NHS activity (Fig. 3 a). 
The  distribution  of  Hp  in  the  NHS  fractions  corre- 
sponded to the known sizes of the different Hp types (Fig. 
4,  a-c);  Hp  1-1  is  a  dimer,  whereas  Hp  2-1  and  2-2  are 
polymers  (11).  Only  in  NHS  containing  Hp  1-1  was en- 
dogenous Hp effectively separated from TLF1  (Fig. 4 a). In 
NHS of lip 2-1 and 2-2, endogenous Hp was found in the 
same fractions  as  TLF1  (Fig.  4,  b and  c).  Taken  together, 
these data strongly suggest that TLF1  activity was not  de- 
tected  in  Hp  2-2  and  2-1  NHS  because  endogenous  Hp 
cofractionates with TLF1  and inhibits its activity. 
Density  Gradient Fractionation of TLF1 and TLF2.  To 
demonstrate that indeed endogenous Hp was inhibiting TLF1 
activity in NHS (Hp 2-1), nonlytic fractions corresponding 
to the expected position of the "masked" TLF1 peak in the 
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Figure  4.  Gel filtration of individual sera containing 
different Hp allotypes. NHS of Hp type 1-1  (a and e), 
2-1 (b andj), or 2-2 (c and g), and Hp-deficient serum 
from a patient with  sickle-cell anemia (d and h)  were 
fractionated on a Superose 6 FPLC column.  Fractions 
were assayed  for lyric activity and Hp concentration (a--d). 
Exogenous Hp  (0.25 mg/ml)  was then  added to each 
fraction and the lyric activity was again determined (e-h). 
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Figure 5.  Density  gradient ultracentrifugation.  NHS Hp type 2-1 was 
fractionated on Superose 6 and 12 FPLC columns connected  in tandem. 
TLF2 fractions were pooled (13.2 ml), as were fractions where TLF1 
would normally elute (13.2 ml). 12 ml of each pool was adjusted to a 
density of 1.25 g/ml and the hpoproteins  floated. The total serum, FPLC 
pools, and the floated and infranate fractions  were titrated to determine 
the dilution that killed 50% of the trypanosomes  T. b. brucei (1 U). The 
total units in each pool or fraction  are represented. 
gel filtration profile were pooled and adjusted to e  =  1.25 
g/ml with KBr. After uhracentrifugation, lytic activity was 
recovered in the floated lipoprotein fraction (e < 1.25 g/ml; 
Fig. 5), whereas Hp was located in the infranate (e >1.25 
g/ml).  In contrast to TLF1, when TLF2 was subjected to 
density gradient centrifugation, lyric activity was recovered 
solely in the infranate (Fig. 5). This activity was not inhib- 
itable by Hp and yielded the high molecular weight peak 
when fractionated by gel filtration (not shown). As previ- 
ously noted (5), when TLF1 was purified by density gradi- 
ent ultracentrifugation, there was  a substantial increase in 
activity over that of whole serum (Fig. 5). 
The Effect of Lysosomotrophic Agents on  TLF Activity.  To 
determine ifTLF2, hke TLF1, must be dehvered to the ly- 
sosomes before trypanolysis (7,  8), we tested the effect of 
lysosomotrophic agents  such  as  NH4C1  and  chloroquine. 
Lysis by both purified TLF1 and TLF2 was equally inhib- 
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Figure 6.  Effect  of lysosomotrophic  agents on TLF activity.  Trypano- 
somes T. b. brucei were preincubated  with NH4C1 (2.5-15 raM) foUowed 
by the addition ofTLF1, TLF2, or TBS. Trypanosome  lysis was then de- 
termined. 
ited  by  preincubation  of the  trypanosomes  with  either 
NH4C1 (Fig. 6) or chloroquine (not shown). 
Discussion 
The main finding of this paper is that TLF2, and not the 
better  characterized  minor  HDL  subclass,  TLF1,  is  the 
principal trypanolytic factor in NHS. Even though, as first 
shown by Rifkin  (3),  purified HDL  (TLF1) particles are 
strongly trypanolytic, their activity is  inhibited by Hp,  a 
major component of normal serum. This conclusion is sup- 
ported by several findings. (a) Purified TLF1 activity is in- 
hibited  by  concentrations  of Hp  below  those  found  in 
NHS (Fig.  1), whereas trypanolytic activity of TLF2 is not 
affected (Fig.  4).  (b) Addition of very high concentrations 
of  lip to NHS does not inhibit trypanolytic activity (Fig. 3). 
(c)  Pathological sera  depleted  of Hp  contain  only TLF1, 
and  their trypanolytic activity is  totally inhibited by low 
concentrations of Hp  (Fig.  3).  (d) When NHS containing 
allotypes Hp  1-1,  2-1,  and 2-2  are fractionated gel filtra- 
tion, substantial activity is recovered in the TLF2 fractions. 
The sole NHS displaying TLF1 activity after fractionation 
contains the dimeric Hpl-1, which elutes in fractions later 
than TLF1  (Fig.  4 a). In the other sera,  TLF1 is inhibited 
by the coeluting polymeric Hp 2-1 and 2-2 (Fig.  4, b and 
c).  To confirm this point,  TLF1  trypanolytic activity was 
recovered after removal of Hp (Fig. 5). 
These findings provide the explanation for the large gain 
in trypanolytic activity when hpoprotein fractions are iso- 
lated from NHS  (5).  Flotation of lipoproteins by density 
gradient  uhracentrifugation,  a  procedure commonly used 
to purify TLF1, effectively separates  HDL from serum Hp. 
TLF2 can be recovered in the infranate (Fig. 5), but it loses 
its activity at 4~  within 72 h of isolation; this loss is accel- 
erated by prolonged exposure to the high concentrations of 
KBr used during lipoprotein separation procedures. 
The  mechanism  by  which  Hp  inhibits  TLF1  is  not 
known.  It seems unhkely that Hp displaces  Hb from Hpr 
present in  TLF1,  since the  inhibitory activity of Hp-Hb 
complexes (which form one of the strongest noncovalent 
interactions known)  was  as effective as that of Hp  alone. 
Neither free Hb, which at physiological pH stimulates the 
peroxidation of lipids,  nor isolated Hp--Hb complexes, in 
which the lipid peroxidation is neutralized (24),  have try- 
panolytic  activity.  However,  at  acidic  pH,  the  Hp-Hb 
complex has  a high peroxidase activity in the presence of 
H202,  whereas free Hb is neutrahzed. Although the pre- 
dicted amino acid sequence of Hpr (10)  should allow Hb 
binding, there is no biochemical evidence for this complex, 
or that it contains peroxidase activity (25). 
An  alternative  explanation for the  inhibitory effects of 
Hp, is that Hpr is the TLF1 ligand for trypanosome recep- 
tors, and that serum Hp competes with Hpr for these re- 
ceptors. Consistent with this idea, polyclonal antibodies to 
Hp  (which also recognize Hpr) prevent trypanosome lysis 
by purified TLF1 (9).  Since TLF2 is not inhibited by Hp, 
the trypanosome receptors for TLF2 and TLF1 may be dis- 
tinct. Our results indicate that both lyric factors need to en- 
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tolytic effect, as TLF1 and TLF2 are equally well inhibited 
by  the  weak  base  NH4C1  (Fig.  6)  and  chloroquine  (not 
shown). 
We have noted that TLF2 is either absent  or much di- 
minished  in some  of the  highly lytic sera  from PNH  pa- 
tients. The reason for this deficit is unknown. Further stud- 
ies  with  additional  sera  are needed  to verify whether  Hp 
deficiencies  are  always associated  with  TLF2  deficiencies. 
Of note, Hp deficiencies are frequently observed in Africa 
and  other  areas  in  which  trypanosomiasis  and  malaria  are 
endemic  (26),  and Hpr gene amplification has been docu- 
mented in American Blacks (27).  Clarification of the issues 
raised  by  these  observations  requires  elucidation  of the 
structure of TLF2 and whether it is a single molecule or a 
complex  sharing  components,  such  as  Hpr,  with  TLF1. 
Our  finding  that  Hp  has  such  a  profound  effect  on  try- 
panolysis in NHS also raises the possibility that Hp or struc- 
turally related molecules modulate the destruction of T.  b. 
brucei by sera from some game animals in Africa. Whereas 
we find no correlation between human Hp types and try- 
panolytic activity, it is intriguing that Hp from most non- 
human  species  resembles  the  dimeric  human  Hp  1-1, 
whereas Hp from sera of many African game animals  (Ar- 
tiodactyla) is polymeric, similar to human Hp 2-1  and 2-2 
(11).  Current  efforts in  our laboratory are  directed  at  an- 
swering some of these questions. 
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Note added in proof." Aider the submission of this manuscript,  an article reporting an inverse correlation  be- 
tween Hp concentration and trypanolytic activity of NHS was published  (Smith, B. and S.L. Hajduk.  1995. 
Proc. Natl. Acad. Sci. USA. 92:10262-10266).  In the current paper however we show otherwise  (Table  1). 
Because a low number of  serum samples were analyzed in both reports, we subsequently repeated our deter- 
minations with an increased sample number and have confirmed that there is no correlation between the Hp 
concentration of  NHS and its trypanolytic activity. These results are currently in press (Raper, J., V. Nussen- 
zweig, and S. Tomlinson. 1996. Mol. Biochem. Parasitol. 76:337-338). 
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